Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Innovent and Shenogen study Tyvyt-SNG1005 combination for cancer

pharmaceutical-technologyAugust 07, 2019

Tag: Innovent , Shenogen , cancer

PharmaSources Customer Service